Valvular & structural heart diseaseRandomised controlled trial
Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial
- Cluster randomised controlled trial
- prospective
- multicentre
Authors' conclusion
The intervention was simple and fast to implement, and was effective and safe to reduce LOS and increase the proportion of patients discharged early after TAVI
Study context
- Population
- Patients with severe symptomatic AS undergoing transfemoral transcatheter aortic valve implantation (TAVI)
- Participants
- 969 vs 860
- Comparison
- Training programme to reduce length of stay (LOS) vs control
- Interventionn = 969
- Controln = 860reference
- Primary endpoint
- Proportion discharged early (within 3 days)
Primary result
As reported in the abstract
Early discharge within 3 days
P < 0.0001
Secondary outcomes
LOS
P < 0.0001
30-day mortality
P = 0.30
Safety
30-day readmission
P = 0.28
Original publication
Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial. Eur Heart J. Published 4 March 2024. doi:10.1093/eurheartj/ehae081
Summarised from the published abstract; every number is checked against it